These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15149664)

  • 1. Exploring the possible binding sites at the interface of triosephosphate isomerase dimer as a potential target for anti-tripanosomal drug design.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3151-4. PubMed ID: 15149664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural considerations for the rational design of selective anti-trypanosomal agents: the role of the aromatic clusters at the interface of triosephosphate isomerase dimer.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Biochem Biophys Res Commun; 2005 Mar; 328(4):922-8. PubMed ID: 15707966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inactivation of triosephosphate isomerase from Trypanosoma cruzi by brevifolin carboxylate derivatives isolated from Geranium bellum Rose.
    Gayosso-De-Lucio J; Torres-Valencia M; Rojo-Domínguez A; Nájera-Peña H; Aguirre-López B; Salas-Pacheco J; Avitia-Domínguez C; Téllez-Valencia A
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5936-9. PubMed ID: 19733070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of triosephosphate isomerase from Trypanosoma cruzi by an agent that perturbs its dimer interface.
    Téllez-Valencia A; Olivares-Illana V; Hernández-Santoyo A; Pérez-Montfort R; Costas M; Rodríguez-Romero A; López-Calahorra F; Tuena De Gómez-Puyou M; Gómez-Puyou A
    J Mol Biol; 2004 Aug; 341(5):1355-65. PubMed ID: 15321726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The design and inhibitory profile of new benzimidazole derivatives against triosephosphate isomerase from Trypanosoma cruzi: a problem of residue motility.
    Romo-Mancillas A; Téllez-Valencia A; Yépez-Mulia L; Hernández-Luis F; Hernández-Campos A; Castillo R
    J Mol Graph Model; 2011 Sep; 30():90-9. PubMed ID: 21798779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyr74 is essential for the formation, stability and function of Plasmodium falciparum triosephosphate isomerase dimer.
    Espinoza-Fonseca LM; Wong-Ramírez C; Trujillo-Ferrara JG
    Arch Biochem Biophys; 2010 Feb; 494(1):46-57. PubMed ID: 19914198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.
    Alvarez G; Aguirre-López B; Varela J; Cabrera M; Merlino A; López GV; Lavaggi ML; Porcal W; Di Maio R; González M; Cerecetto H; Cabrera N; Pérez-Montfort R; de Gómez-Puyou MT; Gómez-Puyou A
    Eur J Med Chem; 2010 Dec; 45(12):5767-72. PubMed ID: 20889239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivatization of the interface cysteine of triosephosphate isomerase from Trypanosoma brucei and Trypanosoma cruzi as probe of the interrelationship between the catalytic sites and the dimer interface.
    Pérez-Montfort R; Garza-Ramos G; Alcántara GH; Reyes-Vivas H; Gao XG; Maldonado E; de Gómez-Puyou MT; Gómez-Puyou A
    Biochemistry; 1999 Mar; 38(13):4114-20. PubMed ID: 10194326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly specific inactivation of triosephosphate isomerase from Trypanosoma cruzi.
    Téllez-Valencia A; Avila-Ríos S; Pérez-Montfort R; Rodríguez-Romero A; Tuena de Gómez-Puyou M; López-Calahorra F; Gómez-Puyou A
    Biochem Biophys Res Commun; 2002 Jul; 295(4):958-63. PubMed ID: 12127988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theoretical analysis of intermolecular interactions of selected residues of triosephosphate isomerase from Trypanosoma cruzi with its inhibitor 3-(2-benzothiazolylthio)-1-propanesulfonic acid.
    Chávez-Calvillo R; Costas M; Hernández-Trujillo J
    Phys Chem Chem Phys; 2010 Mar; 12(9):2067-74. PubMed ID: 20165754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between the subunits of the homodimeric enzyme triosephosphate isomerase.
    Zomosa-Signoret V; Aguirre-López B; Hernández-Alcántara G; Pérez-Montfort R; de Gómez-Puyou MT; Gómez-Puyou A
    Proteins; 2007 Apr; 67(1):75-83. PubMed ID: 17221869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New chemotypes as Trypanosoma cruzi triosephosphate isomerase inhibitors: a deeper insight into the mechanism of inhibition.
    Alvarez G; Martínez J; Aguirre-López B; Cabrera N; Pérez-Díaz L; de Gómez-Puyou MT; Gómez-Puyou A; Pérez-Montfort R; Garat B; Merlino A; González M; Cerecetto H
    J Enzyme Inhib Med Chem; 2014 Apr; 29(2):198-204. PubMed ID: 23406473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking and molecular dynamics simulation studies of Trypanosoma cruzi triosephosphate isomerase inhibitors. Insights into the inhibition mechanism and selectivity.
    Minini L; Álvarez G; González M; Cerecetto H; Merlino A
    J Mol Graph Model; 2015 May; 58():40-9. PubMed ID: 25829097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural differences in triosephosphate isomerase from different species and discovery of a multitrypanosomatid inhibitor.
    Olivares-Illana V; Pérez-Montfort R; López-Calahorra F; Costas M; Rodríguez-Romero A; Tuena de Gómez-Puyou M; Gómez Puyou A
    Biochemistry; 2006 Feb; 45(8):2556-60. PubMed ID: 16489748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrophobic repacking of the dimer interface of triosephosphate isomerase by in silico design and directed evolution.
    Peimbert M; Domínguez-Ramírez L; Fernández-Velasco DA
    Biochemistry; 2008 May; 47(20):5556-64. PubMed ID: 18439027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of the reactivation kinetics of homodimeric triosephosphate isomerase from unfolded monomers.
    Zomosa-Signoret V; Hernández-Alcántara G; Reyes-Vivas H; Martínez-Martínez E; Garza-Ramos G; Pérez-Montfort R; Tuena De Gómez-Puyou M; Gómez-Puyou A
    Biochemistry; 2003 Mar; 42(11):3311-8. PubMed ID: 12641463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural effects of a dimer interface mutation on catalytic activity of triosephosphate isomerase. The role of conserved residues and complementary mutations.
    Banerjee M; Balaram H; Balaram P
    FEBS J; 2009 Aug; 276(15):4169-83. PubMed ID: 19583769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perturbation of the dimer interface of triosephosphate isomerase and its effect on Trypanosoma cruzi.
    Olivares-Illana V; Rodríguez-Romero A; Becker I; Berzunza M; García J; Pérez-Montfort R; Cabrera N; López-Calahorra F; de Gómez-Puyou MT; Gómez-Puyou A
    PLoS Negl Trop Dis; 2007 Oct; 1(1):e1. PubMed ID: 17989778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of triosephosphate isomerase from Trypanosoma cruzi in hexane.
    Gao XG; Maldonado E; Pérez-Montfort R; Garza-Ramos G; de Gómez-Puyou MT; Gómez-Puyou A; Rodríguez-Romero A
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10062-7. PubMed ID: 10468562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,2,4-thiadiazol-5(4H)-ones: a new class of selective inhibitors of Trypanosoma cruzi triosephosphate isomerase. Study of the mechanism of inhibition.
    Alvarez G; Aguirre-López B; Cabrera N; Marins EB; Tinoco L; Batthyány CI; de Gómez-Puyou MT; Puyou AG; Pérez-Montfort R; Cerecetto H; González M
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):981-9. PubMed ID: 22803666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.